Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Wave Life Sciences (WVE) Shares Outstanding (Diluted Average) (2021 - 2025)

Wave Life Sciences' Shares Outstanding (Diluted Average) history spans 5 years, with the latest figure at $168.6 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Diluted Average) rose 21.96% year-over-year to $168.6 million; the TTM value through Dec 2025 reached $168.6 million, up 21.96%, while the annual FY2025 figure was $168.6 million, 21.96% up from the prior year.
  • Shares Outstanding (Diluted Average) reached $168.6 million in Q4 2025 per WVE's latest filing, up from $167.7 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $168.6 million in Q4 2025 to a low of $50.0 million in Q2 2021.
  • Average Shares Outstanding (Diluted Average) over 5 years is $107.5 million, with a median of $105.8 million recorded in 2023.
  • Peak YoY movement for Shares Outstanding (Diluted Average): soared 68.64% in 2023, then grew 21.96% in 2025.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $51.8 million in 2021, then soared by 52.16% to $78.9 million in 2022, then surged by 34.55% to $106.1 million in 2023, then surged by 30.33% to $138.3 million in 2024, then increased by 21.96% to $168.6 million in 2025.
  • Per Business Quant, the three most recent readings for WVE's Shares Outstanding (Diluted Average) are $168.6 million (Q4 2025), $167.7 million (Q3 2025), and $164.0 million (Q2 2025).